The interaction of regulated forms of cell death in the pathogenesis of severe facial paralysis and potential therapeutic strategies
Tang X., Ji Z., Xiao X., Zhu T., Lan S., Yen Y.
Narrative Review on Neuroinflammation, published in Front Neurosci (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- Front Neurosci (2025)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 41459564
- PMCID
- PMC12741114
- DOI
- 10.3389/fnins.2025.1720961
Abstract (original English)
Neuronal cell death plays a central role in the pathogenesis of facial paralysis. In the constructed severe facial paralysis model, axonal damage becomes the key factor triggering retrograde neuronal degeneration, resulting in a large number of neuronal deaths, which seriously affects the function of the facial nerve. The basic fibroblast growth factor exhibits strong neuroprotective ability and can significantly reduce the neuronal mortality rate, providing a strong guarantee for neuronal survival. Viral infection is also an important pathogenic factor that cannot be ignored. Viruses such as herpes simplex virus type 1 can trigger neuroinflammation through the immune response, further exacerbating nerve damage. However, recent studies have also brought hope. Neural reconstruction techniques, targeted drugs, and stem cell therapies hold potential value in promoting the recovery of damaged neural functions. These research results reveal that multiple factors affect the survival and function of neurons in facial paralysis through different pathways, laying a theoretical foundation for targeted treatment against neuronal death. In the future, based on these mechanisms, developing new therapies will bring new treatment opportunities for patients with severe facial paralysis, potentially improving their prognosis and significantly enhancing their quality of life, with important clin
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewPubMed
Adipose-Derived Stem Cells in Traumatic Brain Injury: A Systematic Review of Preclinical Studies.
Systematic Review on Neuroinflammation, published in Tissue Eng Regen Med (2026) — summary generated from the PubMed abstract.
- 2026
Tissue Eng Regen Med - Level ASystematic ReviewPubMed
The use of cellular therapies for trigeminal neuralgia: a systematic review of behavioral and molecular outcomes.
Systematic Review with a reported sample of 8 on Neuroinflammation, published in Neurosurg Rev (2026) — summary generated from the PubMed abstract.
- 2026
- n = 8
Neurosurg Rev - Level ASystematic ReviewEurope PMC
Factor XII-A New Therapeutic Target? A Systematic Review
Systematic Review on Cardiovascular Disease, Neuroinflammation, published in Int J Mol Sci (2026) — summary generated from the PubMed abstract.
- 2026
Int J Mol Sci1 citations - Level ASystematic ReviewEurope PMC
Efficacy of Exosome-Based Therapies for Skin Rejuvenation: A Systematic Review of Human Studies
Systematic Review on Neuroinflammation, Skin Aging, published in Cureus (2026) — summary generated from the PubMed abstract.
- 2026
Cureus - Level ASystematic ReviewEurope PMC
Harnessing exosomes in dry eye disease: a triple threat approach
Systematic Review on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in BMC Ophthalmol (2026) — summary generated from the PubMed abstract.
- 2026
BMC Ophthalmol - Level ASystematic ReviewEurope PMC
Safety and Efficacy of Mesenchymal Stem Cell Therapy in Multiple System Atrophy: Systematic Review
Systematic Review with a reported sample of 123 on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in Biologics (2026) — summary generated from the PubMed abstract.
- 2026
- n = 123
Biologics